Effect of testosterone replacement treatment in testosterone deficiency syndrome patients with metabolic syndrome

Seung Min Jeong, Byeong Kuk Ham, Min Gu Park, Mi-Mi Oh, Duck Ki Yoon, Je-Jong Kim, Du Geon Moon

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: This study was conducted to investigate the effect of testosterone replacement treatment (TRT) in testosterone deficiency syndrome (TDS) patients with metabolic syndrome. Materials and Methods: We reviewed the data of 200 men who were diagnosed with TDS and were undergoing TRT between August 2006 and August 2009. The 200 patients were divided into two groups (group 1: 71 patients with metabolic syndrome, group 2: 129 patients without metabolic syndrome) depending on metabolic syndrome, which was diagnosed according to the NCEP III criteria for Asians. Age, BMI (body mass index), waist circumference, serologic tests, AMS (the Aging Males' Symptoms scale), and IIEF (International Index of Erectile Function) were measured. Results: In group 1, waist circumference and fasting glucose were significantly decreased; hemoglobin and total testosterone were increased; and the somatovegetative scale score of the AMS, the total AMS score, the erectile function score of the IIEF, the overall satisfaction score of the IIEF, and the total IIEF score were significantly improved after TRT. On the other hand, in group 2, waist circumference, BMI, total cholesterol, LDL, and fasting glucose were significantly decreased; hemoglobin and total testosterone were increased; and the 2 subscale scores of the AMS (psychologic and somatovegetative), the total AMS score, all subscale scores of the IIEF, and the total IIEF score were significantly improved after TRT. Conclusions: Overall, the patients who had TDS with metabolic syndrome showed less improvement in AMS, IIEF, and serum variables. Therefore, the correction of metabolic syndrome, such as diabetes, obesity, and hypertension, should be considered during TRT.

Original languageEnglish
Pages (from-to)566-571
Number of pages6
JournalKorean Journal of Urology
Volume52
Issue number8
Publication statusPublished - 2011 Aug 1

Fingerprint

Testosterone
Waist Circumference
Therapeutics
Fasting
Hemoglobins
Body Mass Index
Glucose
Serologic Tests
LDL Cholesterol
Obesity
Hypertension
Serum

Keywords

  • Hormone replacement therapy
  • Metabolic syndrome X
  • Testosterone

ASJC Scopus subject areas

  • Urology

Cite this

Effect of testosterone replacement treatment in testosterone deficiency syndrome patients with metabolic syndrome. / Jeong, Seung Min; Ham, Byeong Kuk; Park, Min Gu; Oh, Mi-Mi; Yoon, Duck Ki; Kim, Je-Jong; Moon, Du Geon.

In: Korean Journal of Urology, Vol. 52, No. 8, 01.08.2011, p. 566-571.

Research output: Contribution to journalArticle

Jeong, Seung Min ; Ham, Byeong Kuk ; Park, Min Gu ; Oh, Mi-Mi ; Yoon, Duck Ki ; Kim, Je-Jong ; Moon, Du Geon. / Effect of testosterone replacement treatment in testosterone deficiency syndrome patients with metabolic syndrome. In: Korean Journal of Urology. 2011 ; Vol. 52, No. 8. pp. 566-571.
@article{ed11b7ddbe434c5c99fad8958406f10e,
title = "Effect of testosterone replacement treatment in testosterone deficiency syndrome patients with metabolic syndrome",
abstract = "Purpose: This study was conducted to investigate the effect of testosterone replacement treatment (TRT) in testosterone deficiency syndrome (TDS) patients with metabolic syndrome. Materials and Methods: We reviewed the data of 200 men who were diagnosed with TDS and were undergoing TRT between August 2006 and August 2009. The 200 patients were divided into two groups (group 1: 71 patients with metabolic syndrome, group 2: 129 patients without metabolic syndrome) depending on metabolic syndrome, which was diagnosed according to the NCEP III criteria for Asians. Age, BMI (body mass index), waist circumference, serologic tests, AMS (the Aging Males' Symptoms scale), and IIEF (International Index of Erectile Function) were measured. Results: In group 1, waist circumference and fasting glucose were significantly decreased; hemoglobin and total testosterone were increased; and the somatovegetative scale score of the AMS, the total AMS score, the erectile function score of the IIEF, the overall satisfaction score of the IIEF, and the total IIEF score were significantly improved after TRT. On the other hand, in group 2, waist circumference, BMI, total cholesterol, LDL, and fasting glucose were significantly decreased; hemoglobin and total testosterone were increased; and the 2 subscale scores of the AMS (psychologic and somatovegetative), the total AMS score, all subscale scores of the IIEF, and the total IIEF score were significantly improved after TRT. Conclusions: Overall, the patients who had TDS with metabolic syndrome showed less improvement in AMS, IIEF, and serum variables. Therefore, the correction of metabolic syndrome, such as diabetes, obesity, and hypertension, should be considered during TRT.",
keywords = "Hormone replacement therapy, Metabolic syndrome X, Testosterone",
author = "Jeong, {Seung Min} and Ham, {Byeong Kuk} and Park, {Min Gu} and Mi-Mi Oh and Yoon, {Duck Ki} and Je-Jong Kim and Moon, {Du Geon}",
year = "2011",
month = "8",
day = "1",
language = "English",
volume = "52",
pages = "566--571",
journal = "Korean Journal of Urology",
issn = "2005-6737",
publisher = "Korean Urological Association",
number = "8",

}

TY - JOUR

T1 - Effect of testosterone replacement treatment in testosterone deficiency syndrome patients with metabolic syndrome

AU - Jeong, Seung Min

AU - Ham, Byeong Kuk

AU - Park, Min Gu

AU - Oh, Mi-Mi

AU - Yoon, Duck Ki

AU - Kim, Je-Jong

AU - Moon, Du Geon

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Purpose: This study was conducted to investigate the effect of testosterone replacement treatment (TRT) in testosterone deficiency syndrome (TDS) patients with metabolic syndrome. Materials and Methods: We reviewed the data of 200 men who were diagnosed with TDS and were undergoing TRT between August 2006 and August 2009. The 200 patients were divided into two groups (group 1: 71 patients with metabolic syndrome, group 2: 129 patients without metabolic syndrome) depending on metabolic syndrome, which was diagnosed according to the NCEP III criteria for Asians. Age, BMI (body mass index), waist circumference, serologic tests, AMS (the Aging Males' Symptoms scale), and IIEF (International Index of Erectile Function) were measured. Results: In group 1, waist circumference and fasting glucose were significantly decreased; hemoglobin and total testosterone were increased; and the somatovegetative scale score of the AMS, the total AMS score, the erectile function score of the IIEF, the overall satisfaction score of the IIEF, and the total IIEF score were significantly improved after TRT. On the other hand, in group 2, waist circumference, BMI, total cholesterol, LDL, and fasting glucose were significantly decreased; hemoglobin and total testosterone were increased; and the 2 subscale scores of the AMS (psychologic and somatovegetative), the total AMS score, all subscale scores of the IIEF, and the total IIEF score were significantly improved after TRT. Conclusions: Overall, the patients who had TDS with metabolic syndrome showed less improvement in AMS, IIEF, and serum variables. Therefore, the correction of metabolic syndrome, such as diabetes, obesity, and hypertension, should be considered during TRT.

AB - Purpose: This study was conducted to investigate the effect of testosterone replacement treatment (TRT) in testosterone deficiency syndrome (TDS) patients with metabolic syndrome. Materials and Methods: We reviewed the data of 200 men who were diagnosed with TDS and were undergoing TRT between August 2006 and August 2009. The 200 patients were divided into two groups (group 1: 71 patients with metabolic syndrome, group 2: 129 patients without metabolic syndrome) depending on metabolic syndrome, which was diagnosed according to the NCEP III criteria for Asians. Age, BMI (body mass index), waist circumference, serologic tests, AMS (the Aging Males' Symptoms scale), and IIEF (International Index of Erectile Function) were measured. Results: In group 1, waist circumference and fasting glucose were significantly decreased; hemoglobin and total testosterone were increased; and the somatovegetative scale score of the AMS, the total AMS score, the erectile function score of the IIEF, the overall satisfaction score of the IIEF, and the total IIEF score were significantly improved after TRT. On the other hand, in group 2, waist circumference, BMI, total cholesterol, LDL, and fasting glucose were significantly decreased; hemoglobin and total testosterone were increased; and the 2 subscale scores of the AMS (psychologic and somatovegetative), the total AMS score, all subscale scores of the IIEF, and the total IIEF score were significantly improved after TRT. Conclusions: Overall, the patients who had TDS with metabolic syndrome showed less improvement in AMS, IIEF, and serum variables. Therefore, the correction of metabolic syndrome, such as diabetes, obesity, and hypertension, should be considered during TRT.

KW - Hormone replacement therapy

KW - Metabolic syndrome X

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=80052046642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052046642&partnerID=8YFLogxK

M3 - Article

C2 - 21927705

AN - SCOPUS:80052046642

VL - 52

SP - 566

EP - 571

JO - Korean Journal of Urology

JF - Korean Journal of Urology

SN - 2005-6737

IS - 8

ER -